Got Stocks from QualityStocks Ones To Watch

Got Stocks

Find out which Small-Cap / Micro-Caps should be on your radar. Get the news and information that moves the markets this week and the "Ones to Watch", only at QualityStocks. The "Quality" is Back in Stocks...

Untitled Document

Arrayit Corp. (ARYC)

Arrayit Corp. is a leading life sciences company listed on the OTCQB. It provides unique products and services to empower scientists and clinicians to explore the human genome and the genomes of plants and animals. Arrayit leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment, and cure. Arrayit has its corporate headquarters in Sunnyvale, California.

Arrayit's worldwide business position leverages its broadly used patented microarray manufacturing platform and VIP™ genotyping technology. The company has taken advantage of its proprietary life sciences platform to develop OvaDx®. This is the first definitive diagnostic screening test for early stage detection of ovarian cancer. Arrayit also has pipeline diagnostic tests for Parkinson's Disease, Plavix®, Male Fertility, and Prostate Cancer.

The company's products include Microarrayers, Microarray Scanners, DNA Microarrays, Protein Microarrays, Microarray Printing, Microarray Substrate Slides, Microarray Instruments, Amplification & Labeling, Microarray Tools, Buffers & Solutions, Microarray Cleanrooms, Books & Software, CGH Microarrays, and Microarray Platforms.

Arrayit has signed a Cooperative Research and Development Agreement (CRADA) with the United States Department of Agriculture (USDA) entitled "Rapid and Cost Effective Detection Technologies for Noroviruses and other Foodborne Pathogens." With this agreement, Arrayit and the USDA Agricultural Research Service (USDA ARS) will develop and validate a rapid, portable, cost-effective and high-throughput detection system for the surveillance of multiple bacterial and viral foodborne pathogens.

The expected outcome is a commercial test that will be widely deployed throughout the lifecycle of food production and distribution to ensure that the food supply is safe for consumption. Arrayit and the USDA will use Arrayit's patented and proprietary DNA microarray platform and the USDA's patent pending method to detect DNA sequences present in potentially life-threatening foodborne pathogens that periodically contaminate fruits, vegetables, meats, poultry, and dairy products.

Recently, Arrayit announced an agreement to supply custom Arrayit blood card technology to Vivos' Global Genome Vault - the only private human DNA vault on earth.

Vivos offers an impermeable, impenetrable and permanent DNA storage vault. It has the ability to provide virtually every man, woman and child on Earth, a safe and secure, nuclear blast-proof, underground shelter to store their DNA.

Arrayit Chief Executive Officer, Ms. Rene Schena, stated, "We are pleased to partner with Vivos on this ambitious scientific project. Rapid advances in biomedical research offer the promise of future scientific breakthroughs based on high quality archival genomic DNA."




The QualityStocks

Read the articles covering the biggest movers in the markets today.



Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks markets.


The QualityStocks Daily

Go back to see our previous newsletters and find out what you might have missed.